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U2 auxiliary factor (U2AF) is an important component of the eukaryotic spliceosome and is 
essential for pre-mRNA splicing in Schizosaccharomyces pombe.  Studies have shown that RNA binding 
is required for U2AF’s role in spliceosome assembly.  We have found temperature sensitive mutants of 
U2AF that inhibit splicing of most pre-mRNA transcripts at a restrictive temperature.  However, some 
transcripts are still spliced at the restrictive temperature, suggesting a splicing pathway independent of 
U2AF.  Determining if the temperature sensitive mutants of U2AF are binding the mRNA is an important 
first step towards identifying an alternative splice pathway.  If the U2AF mutants fail to bind the mRNA, 
this could suggest the existence of a non-canonical splicing pathway that functions in the absence of 
U2AF. Splicing could occur through the presence of a strong 5’ splicing sequence, or perhaps through the 
actions from an as yet unidentified splice factor. The following work lays the groundwork for determining 
















































When pre-mRNA is first transcribed from the eukaryotic genome, it can contain intron and exon 
regions.  Intron sequences must be removed from pre-mRNA transcripts before they can be translated into 
functional proteins through a process called splicing. Splicing results in the removal of the intronic 
sequence and the joining of the two flanking exons. Defects in splicing can have potentially deleterious 
effects on the cell and can lead to diseases such as spinal muscular atrophy (10).    
In higher eukaryotes, pre-mRNA transcripts can give rise to multiple mature mRNA transcripts 
and protein products.  This ability to pick and choose which exons or splice sites to use and which to 
ignore is known as alternative splicing.  The ability of one transcript to produce multiple mRNA isoforms 
is an important feature that generates mRNA and protein diversity. (10) An example of the importance of 
alternative splicing can be seen in the 
development of Drosophila 
melanogaster, here, the pre-mRNA 
transcript of the gene, transformer (tra), is 
alternatively spliced in a sex specific 
manner that results in a protein that is 
only active in the development of female 
flies.  
Alternative splicing in eukaryotes 
is complex, requiring the binding of 
intronic splicing signals by splicing 
factors and the subsequent formation of 
the spliceosome. 
The spliceosome is composed of 
the snRNPs U1 – U6, the splicing factor 
U2AF (U2 auxiliary factor), and other 
splicing proteins.  Some of these 
components bind specific sequences in 
the intron to form the foundation of the 
spliceosome.   
Figure 1.  Formation of the commitment complex on a conventional 
intron.  The intron contains a 5’ splice site (SS), a 3’ splice site, a 
branchpoint sequence (BPS), and a conventional py-tract located between 
the BPS and 3’SS. These sequences are recognized and bound by 
components of the spliceosome to initiate splicing. U1 binds the 5’ SS, 
while U2AF small subunit binds the 3’SS and U2AF large subunit binds 
the py-tract. U2AF binding stabilizes the intron to facilitate the binding of 
U2 with the BPS. U2 is phosphorylated by the protein SF1, which 
commits the intron to splicing. 
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Basic intronic splicing signals include the 
5’ splice site (5’ SS), the 3’ splice site (3’ SS), the 
branchpoint sequence (BPS) located between the 
5’ SS and 3’ SS, and the polypyrimidine tract (py-
tract).  A canonical py-tract is located between the 
BPS and the 3’ SS and is four pyrimidines or 
longer.  Non-canonical py-tracts can exist 
upstream of the BPS and/or the 5’SS, and some 
introns lack a py-tract (11).  
The commitment complex is the foundation and first step of spliceosome assembly. In this step, 
U1 binds the 5’ SS, followed by U2AF binding to the 3’ SS and the py-tract. U2AF stabilizes U2 binding 
to the BPS. U2 phosphorylation by the splicing protein SF1 commits the intron to splicing (Figure 1).  
(12)   
Previous work shows that defects in the functional domains of U2AF results in intron retention 
through a loss of U1-U2 interaction (12).  The structure of U2AF is composed of a large and a small 
subunit. The small subunit of U2AF binds the 3’ SS and contains an RNA recognition motif (RRM), and 
a zinc binding domain (5).  The large subunit of U2AF (S. pombe U2AF59)) binds the py-tract.  U2AF59 
has a C-terminal RNA binding domain consisting of three RRMs (RRM1, RRM2, and RRM3) joined by 
short linker regions (Figure 2).  RRM1 and RRM2 have been shown to be sufficient for py-tract 
recognition in S. pombe (1).  RRM3 has been shown to be necessary for U2AF59 activity in vivo (1), but 
its function has not been completely characterized in S. pombe.  In humans, the RRM3 domain of the 
large subunit of U2AF is responsible for protein-protein interactions between U2AF and other splicing 
factors, and homologs show that the RRM3 domain contains protein interaction elements.  The N-
terminal of large subunit U2AF contains an arginine-serine rich (RS) domain that interacts with the BPS 
to help stabilize U2 binding. 
U2AF is an essential splicing factor, the loss of this protein results in cell death. It is therefore 
important to use a temperature sensitive mutant of U2AF, which allows cells to grow when the protein is 
in its properly folded form. Temperature sensitive mutants of U2AF are a powerful tool that allow us to 
study the phenotypic effects of a mutant protein above a certain temperature (restrictive temperature) 
while preserving the protein’s function below the restrictive temperature (permissive temperature). 
Temperature sensitive mutations are generated through random mutagenesis, and resulting screened 
mutants are used for both in vitro and in vivo assays. (3) 
      Previously, we have shown that temperature sensitive mutations of the linker regions surrounding 
Figure 2. Structure of the large subunit of U2AF showing 
RRM1 and RRM2. RRM1 and RRM2 are the RNA binding 
domains of the large subunit and are composed of α helices and 
β sheets. The RRM domains are joined by short linker regions. 
From Sickmier et al, 2006.  
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the RRM1 and RRM2 domains of U2AF59 result in intron retention in pre-mRNA containing canonical 
py-tracts at the restrictive temperature (11) (Figure 3).  This is ostensibly because these mutations prevent 
the large subunit from recognizing and binding the py-tract. Additionally, introns that lack py-tracts have 
shown a strong requirement for U2AF59 (11).  However, some introns with noncanonical py-tracts have 
exhibited splicing activity at the restrictive temperature (11) (Figure 3). Defects in the functional domains 
of U2AF should result in defects in splicing through a loss of U2 binding to the BPS and interacting with 
U1 (12).  S. pombe intron splicing at the restrictive temperature is contrary to this hypothesis and suggests 
another mechanism of splicing that functions independently of U2AF.  A first step to determining the 
existence of another splicing mechanism is defining the way in which temperature sensitive mutations of 
U2AF59 RRM1 and RRM2 inhibit splicing. Specifically, we would like to determine the binding 
capabilities of the mutants. If the mutants are not binding the mRNA, the presence of an alternative splice 
factor binding and stabilizing the spliceosome is possible. 
We have two temperature sensitive mutants of S. pombe U2AF59 (prp2.1, RRM1-16) that inhibit 
splicing of most pre-mRNA transcripts at a restrictive temperature of 37°C. Prp2.1 is a mutation located 
in the linker region between RRM2 and RRM3, and changes a cysteine to a tyrosine.  Prp2.1 has been 
tested for splicing defects in vivo (Figure 3). RRM1-16 is a mutation in the linker region between RRM1 
and RRM2, and results in three amino acid changes: an asparagine to a threonine, a phenylalanine to an 
alanine, and an isoleucine to an alanine.  RRM1-16 has not yet been tested in vivo.   The binding abilities 
of prp2.1 and RRM1-16 will be compared to those of the large 
subunit of wild type human U2AF (hU2AFΔ1-63) and S. pombe 
U2AF59 (prp2.0+). hU2AFΔ1-63 is used here because it is the most 
extensively studied U2AF homolog, and its activity can be used as a 
comparison for S.pombe U2AF. All of the proteins lack RRM3 and 
the RS domain, as this interferes with in vitro expression and binding 
assays. 
Here, I lay the groundwork for analyzing the binding ability 
of the temperature sensitive mutants of U2AF59. 
 
Materials and Methods 
Subcloning 
 An hU2AFΔ1-63 in pGEX6p1 miniprep was obtained from the 
Blumenthal lab and directly cloned into BL21 cells.  Prp2.0+ in 
Figure 3. TS mutations of the large 
subunit of pU2AF result in intron 
retention in some, but not all pre-
mRNA transcripts. The ts mutant 
prp2.1 shows intron retention of the 
transcripts cdc2.2, cdc16.2 and p14.1.  
However, splicing still occurs for the 
transcript SPBC27 at the nonpermissive 
temperature.  SPBC27 has a long py-tract 
(more that eight pyrmindines). Prp2.0+ is 
the wild type, and shows splicing of all 
transcripts. From Sridharan and Singh, 
2007. 
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pGEX6pI was purified from MC061 cells and cloned into BL21 cells.  Prp2.1 in pGEX6p1 was cloned 
directly into BL21 cells.  RRM1-16 was pcr amplified using Phusion polymerase with the following 
primers: 
Forward 5’ GCGGGATCCTTACAACCAGGTGCTAGCAGACAGGC 3’  
Reverse 5’ CGCCTCGAGTCACCATGCATTAGCTTTATAGCAATCCTCA 3’ 
The forward primer was supplemented with a BamHI cut site while the reverse primer contained a Xho1 
site.  After pcr, the product was gel purified and cut with BamHI and XhoI and ligated into pGEX6p-1.  
The ligated product was then transformed into DH5α competent cells to repair the nicks surrounding the 
ligation sites of insert into vector.  The repaired plasmid was then transformed into BL21 cells. 
 To check the accuracy of all the plasmids (except for hU2AFΔ1-63), the cells were screened for 
ampicillin resistance, and isolated plasmids from screened cells were digested using BamHI and XhoI.  
Plasmids showing cut products were sent to ACGTinc for sequencing.    
Protein Expression and Purification 
  hU2AFΔ1-63 was induced with 0.1 mM IPTG for 3 hours at 37°C,  prp2.0+ was induced 
with 0.1 mM IPTG for 18 hours at 22°C.  Both hU2AFΔ1-63 and prp2.0+ were successfully column 
purified at 4°C using glutathione agarose beads. 
Prp2.1 and RRM1-16 induction temperatures were tested at 37°C, 22°C, and 10°C.  Time points 
were set at 1, 4, and 18 hours.  IPTG concentration was help at 0.1 mM. Appropriate expression 
conditions were determined to be 10°C for 18 hours.  Cells were then sonicated, and an SDS gel revealed 
the presence of proteins aggregated into inclusion bodies. 
Gel Mobility Shift Assay 
 Cdc2_b intron was hot labeled with αP32 GTP using T7 RNA polymerase.  The RNA product was 
gel purified in a denaturing polyacrylamide gel. 
Purified hU2AFΔ1-63 was combined with radiolabeled cdc2_b mRNA at varying concentrations.  
Binding reactions were incubated for 30 minutes at 37°C, then run on a 5% native polyacrylamide gel.  




 All protein sequences were inserted into a pGEX6p-1 vector containing ampicillin as a selectable 
marker, an IPTG inducible lac promoter, and an N-terminal GST tag for purification (Figure 4).  Prp2.0+, 
prp2.1, and rrm1-16 colonies were screened for proper insertion through a BamHI, XhoI restriction digest 
and selected colonies sequenced.  Sequenced colonies were selected based on the evidence of cut 
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products (Figure 5).  It is interesting to 
note that rrm1-16 colonies show an 
extra band, although sequencing data 
did not reveal the presence of an 
internal cut site. The sequencing data 
show that prp2.0+, prp2.1 col 2, and 
rrm1-16 colonies 1, 3, and 4 all are 
correct (Figure 6). 
Protein expression and purification 
 Prp2.1 colonies 1, 2 and 
4, and rrm1-16 colonies 1, 3, and 4 were 
first tested for expression by induction 
of a small culture with 0.1 mM IPTG 
for 1 hour at 37°C.  SDS gel analysis indicated that prp2.1 colony 2, and rrm1-16 colonies 3 and 4 had the 
highest levels of expression during the allotted time. However, expression for these mutant colonies was 
inconsistent and generally very low (Figure 7), with the cultures themselves growing at a much slower 
rate than the wild type cultures.  Additionally hU2AFΔ1-63 and prp2.0+ showed no significant difference in 
their expression.  
hU2AFΔ1-63 and prp2.0+ were expressed and purified on a glutathione agarose column. Presence 
of purified protein was detected on an SDS gel, and protein containing fractions were combined and 
concentrated (Figure 8). 
Purification was carried out on rrm1-16 colony 3 because it appeared to express at a higher level 
than prp2.1 colony 2. However, during purification, the protein remained within the sonication pellet, 
indicating the presence of a high volume of inclusion bodies (Figure 9).  To remedy this situation, the 
sonication pellet was dissolved in buffer containing 8 M urea and dialyzed against the same buffer 
containing no urea for four days. However, this failed to yield enough protein to use for in vitro assays.  
Because inclusion bodies can form as a result of protein overexpression, the induction time was shortened 
to four hours, but again, this failed to yield enough protein to continue.  Adjustments to induction 
temperature and IPTG concentration either continued to yield inclusion bodies, or resulted in low 
expression. Difficulties obtaining usable protein may indicate the inherent instability of RRM1-16. 
Prp2.0+ and hU2AFΔ1-63 produced a low level of inclusion bodies that did not interfere with protein 
purification. 
 
Figure 4. Schematic of the pGEX6p-1 vector. pGEX6p-1 is an 
expression vector that contains an IPTG inducible lac promoter, a GST 
gene incorporated at the N terminal of the target protein, and an 
ampicillin resistance gene for plasmid selection.   
  9 
Gel Mobility Shift Assay  
 Purified hU2AFΔ1-63 was diluted 
10X and 100X.  These dilutions were 
incubated with αP32 labeled cdc2_b 
mRNA and analyzed on a 5% native gel. 
Cdc2_b is a canonical intron that has 
previously shown retention with prp2.1 in 
in vivo assays. The 10X dilution migrated 
more slowly on the gel, which is indicative 
of protein bound RNA, while the 100X 
migrated to the same place as the control 
(Figure 10).  This result indicates that 
hU2AFΔ1-63 binds cdc2_b mRNA in a 
concentration dependent manner. 
 
Discussion 
 The purpose of this project was to analyze the RNA binding capability of prp2.1 and rrm1-16 
through an in vitro binding assay, and compare these proteins with wild type versions hU2AFΔ1-63 and 
prp2.0+. We have found that there is no difference in the expression profile between hU2AFΔ1-63 and 
prp2.0+ in a heterologous system, and that functional hU2AFΔ1-63 can be expressed and purified. We have 
Figure 6. Sequence results of selected colonies.  Prp2.1 colony 2 and RRM1-16 colonies 1, 3, and 4 were sent to ACGTinc 
for sequencing.  Here, the mutant sequences are compared to the wild type prp2.0+ and mutated residues are highlighted with 
a ★.  The prp2.1 mutation is a single point mutation that occurs at the 1160 base in the full length prp2.0+.  This mutation is 
located in the linker region between RRM2 and RRM3 and changes a cysteine residue into a tyrosine residue.  The RRM1-16 
mutation consists of five point mutations at bases 737, 739, 740, 745, and 746 in the full length prp2.0+.  These mutations are 
located in the linker region between RRM1 and RRM2.  The mutations change an asparigine residue to a threonine, a 
phenylalanine to an alanine residue, and an isoleucine to an alanine. 
Figure 5. Digest of selected colonies.  DNA from selected BL21 clones 
of prp2.1 and rrm1-16 was digested with BamHI and XhoI for four 
hours at 37°C. A band migrating to 900kb indicates presence of the 
insert. hU2AFΔ1-63 lacking BamHI, XhoI cuts sites was used as the 
negative control. Prp2.0+ inserted with BamHI, XhoI was used as the    
positive control. 
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also found that mutation is 
influencing the expression of prp2.1 
and rrm1-16, and influencing the 
folding of rrm1-16. 
To date, hU2AFΔ1-63 has been 
purified and its binding activity to 
canonical intron cdc2_b analyzed 
using a gel mobility shift assay. As 
expected, hU2AFΔ1-63 binds cdc2_b 
in a concentration dependent manner, 
which is consistent with previous 
results on other introns (7). Prp2.0+ 
has also been found to bind cdc2_b intron in a concentration dependent manner in previous work from the 
Singh lab (11).  Taken together, these results show that in vitro analysis of wild type U2AF yields 
functional proteins. 
Comparing the success of purifying the wild type proteins with the difficulties of purifying the 
mutants shows that the mutations in U2AF59 are influencing both the expression levels and folding of this 
essential protein.  Prp2.1 and rrm1-16 expressed at much lower levels then their wild type counterparts. 
These mutants also grew at a slower rate (Figure 6). In addition, purifying prp2.1 and rrm1-16 for 
functional analysis has proven to be difficult. One reason for this difficulty is the inherent instability that 
point mutations introduce to protein structure.  Point mutations that change the coded amino acid can 
affect the tertiary structure of the protein, causing the protein to misfold and expose hydrophobic 
residues.  Aggregates of misfolded proteins (inclusion bodies) form to cover the exposed hydrophobic 
residues. Misfolded proteins and inclusion bodies can prove toxic to the cellular environment, which 
could explain why prp2.1 and rrm1-16 grew more slowly than their wild type counterparts.  Inclusion 
bodies are insoluble and nonfunctional.  Inclusion bodies can be purified through denaturation to break up 
the protein aggregates, and then carefully refolding the proteins through dialysis. However, the process of 
denaturing and then refolding the proteins results in a loss of functional, properly folded protein. Prp2.1 
and rrm1-16 colonies were already growing at a slow rate and not producing proteins in high volumes 
such that denaturing the inclusion bodies did not present itself as an efficient way to obtain usable 
quantities of protein.  
The sensitive nature of these prp2.1 and rrm1-16 mutants requires precise expression conditions to 
prevent misfolding and formation of inclusion bodies within the cells.  There are three main ways to  
Figure  7.  Expression  comparison  of  selected  colonies.  hU2AFΔ1‐63, prp2.0+,  prp2.1  colony  2,  and  RRM1‐16  colony  3 were  induced with 0.1 mM IPTG and grown for 1 hour at 37°C. The “‐“ represents samples taken directly before IPTG induction, the “+” represents samples taken after one hour. The protein band of interest is located between 64 and 82 kDa. 
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Figure 8. SDS analysis of purification of hU2AFΔ1­63 and prp2.0+ proteins. Panels A and B show purification of hU2AFΔ1‐63 protein, panels C and D show purification of prp2.0+ preotein.  Both cultures were induced with 0.1 mM IPTG  and  sonicated  for  ten minutes.  Samples  taken  at  0  and  5 minutes  show  increase  in  soluble  protein  in  the sonication  lysate.    Soluble  proteins  were  incubated  with  glutathione  agarose  beads  for  one  hour,  and  purified protein eluted of the column using reduced glutathione.  Panel B shows protein binding to the glutathione agarose beads.  After elution, protein containing fractions were combined and concentrated use a MWCO 30 tube. 
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optimize expression conditions to reduce the formation of inclusion bodies: changing the induction  
temperature, changing the induction time, and changing the concentration of IPTG used. Many different 
optimization conditions were used to try to produce soluble rrm1-16.  Induction temperatures ranging 
from 22°C to 10°C were utilized. Because these proteins are unstable at a high temperature, they should 
be more stable, and therefore properly folded, at a lower temperature. However, inclusion bodies still 
formed at 10°C. Protein overexpression can occur when the induction time is too long, resulting in the 
formation of inclusion bodies, so shorter induction times of four and six hours were used instead of 
eighteen.  At the lower induction times, protein expression was greatly reduced and the presence of 
inclusion bodies remained. Next, IPTG concentration was lowed as a high concentration of IPTG in the 
cell can tax the translation machinery and lead to overexpression. Reducing IPTG from 0.1 to 0.05 mM 
still resulted in protein expression, with the resulting protein still aggregating in inclusion bodies. More 
experimentation is needed to determine whether these mutant proteins can be purified from E. coli.   
The sensitivity of this protein to purification from E. coli complements the in vivo splicing 
defects.  The purification difficulties of the mutants also contrast with the relative ease of hU2AFΔ1-63 and 
prp2.0+ purification, indicating that the mutations are likely interfering with the structure of the protein. 
If this is the case, the structure of the protein in S. pombe at the 
permissive temperature may be incorrect. If the proteins are unable to 
fold properly, then it is highly likely that they are not binding the 
mRNA at a functional level.  However, it can be difficult to purify a 
yeast protein from an E. coli cell that lacks the appropriate cellular 
environment.  Purification of this protein from a plasmid expressing 
from S. pombe could certainly prove to be more fruitful. 
Future Directions 
Prp2.1 and RRM1-16 need to be purified in order for their 
binding activity to analyzed through a gel mobility shift.  Transforming 
these ampicillin resistant plasmids into chloroamphenicol resistant 
competent cells would allow for more stringent plasmid selection, 
which would reduce the number of colonies that lost the insert or 
obtained an improper sequence.   Additionally, the chloroamphenicol 
plasmid is a selection marker for competent cells that contain a 
plasmid that expresses rare eukaryotic tRNA’s. These tRNA’s could 
help alleviate protein misfolding. It might also be useful to grow the 
Figure 9. Rrm1-16 protein 
aggregates into inclusion bodies, 
pellet dialysis fails to yield 
protein. Rrm1-16 culture was 
sonicated for ten minutes after 
induction. A dark band around 82 
kDA in the sonication pellet 
indicates the presence of inclusion 
bodies. Dialysis of the sonication 
pellet fails to yield rrm1-16 protein. 
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cells at a lower temperature before induction. Previously, all of the E. coli 
cells were grown at 37°C. While this generally should not have an effect 
on the formation of inclusion bodies because protein is not being actively 
expressed at this time, it is possible that the baseline level of expression is 
producing misfolded proteins that act as an inclusion body “seed”.  
Changing the growth temperature from the restrictive temperature of 37°C 
to the permissive temperature of 25°C may have a mitigating effect on 
inclusion body formation.  
If inclusion bodies predominate after optimizing expression, I 
would like to try purifying the protein from S. pombe, which has the native 
cellular environment and all the machinery necessary for protein folding.  
We have previously purified prp2.1 from S. pombe to test it for splicing 
defects (11). 
Once the proteins are purified, they should be checked for binding 
to both canonical and noncanonical introns through a gel mobility shift 
assay at the restrictive and permissive temperatures.  Introns used should 
include those that showed no splicing defect with prp2.1 at the nonrestrictive temperature. RRM1-16 
should also be checked for in vivo splicing defects similar to prp2.1 (11), as this protein has not yet been 
fully characterized in S. pombe.  A lack of RNA binding could suggest the presence of an alternative 
splicing pathway that functions on some introns in the absence of functional U2AF.  If this is the case, an 
experiment that isolates the proteins binding the introns that continue to splice at the restrictive 
temperature could reveal a novel element that facilitates splicing through U1-U2 association. If the 
mutants are binding the RNA at the restrictive temperature, then more work needs to be done to 
determine the affect that the mutation has on U2AF function.  Perhaps U2AF is binding to the RNA, but 
not in the normal manner that provides stabilization for U2 recruitment, or perhaps the mutation is 
affecting protein interactions. 
 
Acknowledgements 
I would like to thank everyone in the Singh Lab for their help and support while working on this project. 
Ravinder Singh for giving me this opportunity and guiding me along the way, Vinod Sridharan for his 
technical expertise and advice, Joe Heimiller for his advice and experience, and Anna Kuropatkina and 
Sean Kalra.  Thanks also to Mike Sfregola for his input and the DeDecker lab for the use of some of their 
supplies and protocols.  Finally, I thank my thesis committee, Rui Yi, Nancy Guild, and Dylan Taatjes for 
Figure 10.  Gel mobility shift 
assay of the binding reaction 
between cdc2_b intron and 
hU2AF1-63. The leftmost lane 
cdc2_b intron with no protein 
(negative control).  hU2AF1-63 
shows a strong binding affinity 
for cdc2_b intron at 10x 
diliution, and no binding at 100x 
dilution. 
  14 
taking the time to lend me their ears and guide me with their years of experience. 
References 
1. Banerjee H, Rahn A, Bharat G, Guth S, Valcarcel J, Singh R. 2004. The conserved RNA 
recognition motif 3 of U2 snRNA auxiliary factor (U2AF65) is essential in vivo but dispensable 
for activity in vitro. RNA 10:240-53. 
2. Banerjee H, Rahn A, Davis W, Singh R. 2003. Sex lethal and U2 small nuclear ribonucleoprotein 
auxiliary factor (U2AF65) recognize polypyrimidine tracts using multiple modes of binding. RNA 
9(1):88-99. 
3. Chakshusmathi G, Kajari M, Lakshmi G.S, Singh G, Roy A, Ch R.B, Madhusudhanan S. "Design 
of Temperature-sensitive Mutants Solely from Amino Acid Sequence." PNAS 101(21): 7925-
7930.  
4. Haraguchi N, Andoh T, Frendewey D, Tani T. 2007. Mutations in the SF1-U2AF59-U2AF23 
complex cause exon skipping in Schizosaccharomyces pombe. The Journal of Biological 
Chemistry 282(4):2221-8 
5. Kielkopf CL, Lucke S, Green MR. 2004. U2AF homology motifs: Protein recognition in the RRM 
world. Genes & Development 18:1513-26. 
6. Rino J, Desterro JP, Pacheco TR, Gadella, Jr. TJ, Carmo-Fonseca M. 2008. Splicing factors SF1 
and U2AF associate in extraspliceosomal complexes. Molecular and Cellular Biology 28(9):3045-
57. 
7. Rudner D.Z, Breger K.S, Kanaar R, Adams M.D, Rio D.C. RNA Binding Activity of 
Heterodimeric Splicing Factor U2AF: at Least One RS Domain Is Required for High-affinity 
Binding. Molecular and Cellular Biology 18(7):4004-4011.  
8. Sickmier A.E, Frato K.E, Shen H, Paranawithana S.R, Green M.R, Kielkopf C.L. Structural basis 
for polypyrimidine tract recognition by the essential pre-mRNA splicing factor U2AF65. 
Molecular Cell 23(1):49-59.  
9. Singh R, Banerjee H, Green M. 2000. Differential recognition of the polypyrimidine-tract by the 
general splicing factor U2AF65 and the splicing repressor sex-lethal. RNA 6(6):901-11. 
10. Smith CJ, Valcarcel J. 2000. Alternative pre-mRNA splicing: The logic of combinatorial control. 
Trends in Biochemical Sciences 25(8):381-8. 
11. Sridharan V, Singh R. 2007. A conditional role of U2AF in splicing of introns with unconventional 
polypyrimidine tracts. Molecular and Cellular Biology 27(20):7334-44. 
12. Weaver RF. 2005. Chapter 14 Messenger RNA Processing I: Splicing. In: Molecular Biology, 3rd 
Ed. New York New York: McGraw Hill. p 425-69. 
13. Webb CJ, Wise J. 2004. The splicing factor U2AF small subunit is functionally conserved between 
fission yeast and humans. Molecular and Cellular Biology 24(10):4229-4240. 
 
   
 
 
   
